However, Kras activation alone infrequently leads to development of invasive PDA, while combination with mutations in Cdkn2a, Smad4 or Trp53 can enhance the speed or frequency of progression to invasive disease in GEMM8. The gene discussed is SMAD4; the disease is Patent ductus arteriosus.